Sensitivity of acute myeloid leukaemia cells to colony stimulating activity: relation to response to chemotherapy

British Journal of Haematology
G E FrancisA V Hoffbrand

Abstract

Agar cultures of acute myeloid leukaemia (AML) cells were used to determine the sensitivity of AML clone forming cells to the specific regulator granulocyte-macrophage colony stimulating activity (CSA). The mean CSA threshold (amount of CSA required to stimulate 0.5 of the clone forming cells) of 27 different AML cell samples varied from normal to an approximately nine-fold increase in CSA requirement. The degree of sensitivity to CSA at presentation was found to be closely correlated to the response to induction chemotherapy in 15 patients. There was a highly significant correlation (P less than 0.001) between the mean CSA threshold and the number of courses of chemotherapy required to induce remission. Also, an increased mean CSA threshold at presentation was associated with a significantly slower decline of marrow blasts following the first course of chemotherapy and a reduced remission rate. Sensitivity to CSA was closely related to the clone size achieved in maximally stimulated cultures of AML cells and this in turn also related to the remission rate and ease with which remission was achieved (presentation marrows, 39 patients). Possible reasons for the linking of these two functional properties of AML cells and their rel...Continue Reading

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.